2014 Press Releases

Webcast ImageWebcast
Kindred Biosciences' Second Quarter 2018 Financial Results (Replay)
08/09/18 at 4:30 p.m. ET
Kindred Biosciences' Second Quarter 2018 Financial Results
Thursday, August 9, 2018 4:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014

KindredBio Announces Update on AtoKin and Atopic Dermatitis Program

December 3, 2014

SAN FRANCISCO, California. (December 3, 2014) – Kindred Biosciences, Inc. ... 

KindredBio to Present at Jefferies 2014 Global London Healthcare Conference

November 17, 2014

SAN FRANCISCO, California. (November 17, 2014) – Kindred Biosciences, Inc.... 

KindredBio to Announce Third Quarter 2014 Financial Results

November 6, 2014

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time on Thursda... 

Kindred Biosciences Announces Top-Line Results from Pivotal Study of CereKin in Dogs with Osteoarthritis

August 20, 2014

SAN FRANCISCO, Aug. 20, 2014 /PRNewswire/ -- Kindred Biosciences, Inc. (KindredB... 

Kindred Biosciences Announces Second Quarter 2014 Financial Results

August 13, 2014

SAN FRANCISCO, Aug. 13, 2014 /PRNewswire/ -- Kindred Biosciences, Inc. (NAS... 

KindredBio Schedules Release of 2014 Second Quarter Financial Results and Provides Timeline for Release of CereKin Pivotal Study Data

August 6, 2014

SAN FRANCISCO, Aug. 6, 2014 /PRNewswire/ -- Kindred Biosciences, Inc. (Kind... 

KindredBio to Host Investor Breakfast on June 13 in New York City

June 11, 2014

SAN FRANCISCO, California. (June 11, 2014) – Kindred Biosciences, Inc. (NA... 

KindredBio to Present at Craig-Hallum, Stifel, and Jefferies Conferences

May 21, 2014

SAN FRANCISCO, California. (May 21, 2014) – Kindred Biosciences, Inc. (NASDAQ: K... 

Kindred Biosciences Announces First Quarter 2014 Financial Results and Completion of Enrollment in CereKin Pivotal Study

May 12, 2014

San Francisco, CA (May 12, 2014) Kindred Biosciences, Inc. (NASDAQ: KIN) today a... 

Kindred Bio to Announce First Quarter 2014 Financial Results on Monday, May 12th

May 6, 2014

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time that Day ... 

KindredBio Announces Closing of Public Offering and Exercise of Over-Allotment Option

April 8, 2014

SAN FRANCISCO, April 8, 2014 /PRNewswire/ -- Kindred Biosciences, Inc. (NAS... 

KindredBio to Present at Needham 13th Annual Healthcare Conference

April 4, 2014

SAN FRANCISCO, April 4, 2014 /PRNewswire/ -- Kindred Biosciences, Inc. (NAS... 

Kindred Bio Announces Pricing of Public Offering

April 3, 2014

SAN FRANCISCO, April 3, 2014 /PRNewswire/ -- Kindred Biosciences, Inc. (NAS... 

KindredBio and X-Body Announce an Exclusive Collaboration for Discovery of Antibodies for Companion Animal Health

March 31, 2014

SAN FRANCISCO and WALTHAM, Mass., March 31, 2014 /PRNewswire/ -- Kindred Bi... 

Kindred Bio Announces Launch of Public Offering

March 31, 2014

SAN FRANCISCO, March 31, 2014 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ:... 

Kindred Bio Announces Initiation of Pivotal Clinical Study for SentiKin™ in Dogs

March 28, 2014

SentiKin™, KindredBio's third lead product candidate, is being developed for the... 

KindredBio Appoints Dr. Blake Hawley as Chief Commercial Officer, Announces Upcoming Inclusion in Russell 2000

March 24, 2014

Blake Hawley, D.V.M., Worldwide Director of Global Digital and Former General Ma... 

Kindred Bio Announces Proposed Public Offering

March 18, 2014

SAN FRANCISCO, March 18, 2014 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ:... 

Kindred Biosciences Announces Fourth Quarter and Year End 2013 Financial Results

March 6, 2014

SAN FRANCISCO, March 6, 2014 /PRNewswire/ -- Kindred Biosciences, Inc. (NAS... 

Kindred Bio to Present at Roth Capital Partners 26th Annual Growth Stock Conference

March 4, 2014

SAN FRANCISCO, March 4, 2014 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ... 

Kindred Bio to Announce Fourth Quarter and Year-End Financial Results on Thursday, March 6th

February 27, 2014

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time that DaySA... 

Kindred Bio Announces Initiation of Pivotal Clinical Study for AtoKin™ in Dogs

February 20, 2014

AtoKin™, Kindred Bio's second lead product, is expected to be a major advance in... 

Kindred Bio to Present at 2014 Leerink Global Healthcare Conference

February 6, 2014

SAN FRANCISCO, Feb. 6, 2014 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ... 

New Year's Resolution: Give Pets the Gift of Top-Notch Health Care

January 14, 2014

BURLINGAME, Calif., Jan. 14, 2014 /PRNewswire/ -- As pet owners drew up their li...